SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060270
Filing Date
2023-11-07
Accepted
2023-11-07 16:15:24
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20230930.htm   iXBRL 10-Q 2284155
2 EX-31.1 alec-ex31_1.htm EX-31.1 25226
3 EX-31.2 alec-ex31_2.htm EX-31.2 25223
4 EX-32.1 alec-ex32_1.htm EX-32.1 9746
5 EX-32.2 alec-ex32_2.htm EX-32.2 9787
  Complete submission text file 0000950170-23-060270.txt   6075657

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20230930.xsd EX-101.SCH 32013
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20230930_lab.xml EX-101.LAB 316859
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alec-20230930_def.xml EX-101.DEF 121034
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20230930_pre.xml EX-101.PRE 213922
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alec-20230930_cal.xml EX-101.CAL 34768
45 EXTRACTED XBRL INSTANCE DOCUMENT alec-20230930_htm.xml XML 754298
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 231384106
SIC: 2836 Biological Products, (No Diagnostic Substances)